# The Fibrin Pad Liver Study

> **NCT01166243** · PHASE3 · COMPLETED · sponsor: **Ethicon, Inc.** · enrollment: 84 (actual)

## Conditions studied

- Hemorrhage

## Interventions

- **BIOLOGICAL:** Fibrin Pad
- **PROCEDURE:** Standard of Care

## Key facts

- **NCT ID:** NCT01166243
- **Lead sponsor:** Ethicon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-08
- **Final completion:** 2011-10
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2014-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01166243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01166243, "The Fibrin Pad Liver Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01166243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*